Drug Shortage Report for DELATESTRYL
| Report ID | 191622 |
| Drug Identification Number | 00029246 |
| Brand name | DELATESTRYL |
| Common or Proper name | DELATESTRYL |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | TESTOSTERONE ENANTHATE |
| Strength(s) | 200MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | n/a |
| ATC code | G03BA |
| ATC description | ANDROGENS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-05-04 |
| Estimated end date | 2023-06-07 |
| Actual end date | 2023-05-30 |
| Shortage status | Resolved |
| Updated date | 2023-05-31 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-05-31 | English | Compare |
| v5 | 2023-05-30 | French | Compare |
| v4 | 2023-05-30 | English | Compare |
| v3 | 2023-05-05 | English | Compare |
| v2 | 2023-05-04 | French | Compare |
| v1 | 2023-05-04 | English | Compare |
Showing 1 to 6 of 6